Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Artificial intelligence models in chronic lymphocytic leukemia - recommendations toward state-of-the-art

Research output: Contribution to journalReviewResearchpeer-review

  1. Improved survival after allogeneic transplantation for acute lymphoblastic leukemia in adults: a Danish population-based study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Serological response following vaccination with BNT162b2 mRNA in patients with chronic lymphocytic leukemia

    Research output: Contribution to journalLetterResearchpeer-review

  3. Pancreatitis-associated protein as an early marker of asparaginase-associated pancreatitis

    Research output: Contribution to journalLetterResearchpeer-review

  4. Mutations known from B-cell lymphoid malignancies are not found in CD34+ stem cells from patients with lymphoma

    Research output: Contribution to journalLetterResearchpeer-review

  1. Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The CLL comorbidity index in a population-based cohort: a tool for clinical care and research

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Obinutuzumab (GA-101), ibrutinib, and venetoclax (GIVe) frontline treatment for high-risk chronic lymphocytic leukemia

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Chronic lymphocytic leukaemia clones are detectable decades before diagnosis

    Research output: Contribution to journalLetterResearchpeer-review

View graph of relations

Artificial intelligence (AI), machine learning and predictive modeling are becoming enabling technologies in many day-to-day applications. Translation of these advances to the patient's bedside for AI assisted interventions is not yet the norm. With specific emphasis on CLL, here, we review the progress of prognostic models in hematology and highlight sources of stagnation that may be limiting significant improvements in prognostication in the near future. We discuss issues related to performance, trust, modeling simplicity, and prognostic marker robustness and find that the major limiting factor in progressing toward state-of-the-art prognostication within the hematological community, is not the lack of able AI algorithms but rather, the lack of their adoption. Current models in CLL still deal with the 'average' patient while the use of patient-centric approaches remains absent. Using lessons from research areas where machine learning has become an enabling technology, we derive recommendations and propose methods for achieving state-of-the-art predictions in modeling health data, that can be readily adopted by the CLL modeling community.

Original languageEnglish
JournalLeukemia and Lymphoma
Volume63
Issue number2
Pages (from-to)265-278
Number of pages14
ISSN1042-8194
DOIs
Publication statusPublished - Feb 2022

    Research areas

  • artificial intelligence models, chronic lymphocytic leukemia, CLL, guidelines, model, treatment

ID: 73916634